tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

EWTX Stock Latest News

EMA grants Orphan Drug Designations for Edgewise’s sevasemten to treat Becker
The FlyEMA grants Orphan Drug Designations for Edgewise’s sevasemten to treat Becker
5d ago
EWTX
Edgewise Therapeutics price target raised to $32 from $28 at RBC Capital
PremiumThe Fly
Edgewise Therapeutics price target raised to $32 from $28 at RBC Capital
6d ago
EWTX
Edgewise reports ‘positive’ two-year topline results from ARCH trial
PremiumThe Fly
Edgewise reports ‘positive’ two-year topline results from ARCH trial
13d ago
EWTX
Micron upgraded, Foot Locker downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Micron upgraded, Foot Locker downgraded: Wall Street’s top analyst calls
2M ago
EW
FL
Edgewise Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe Fly
Edgewise Therapeutics initiated with an Overweight at Piper Sandler
2M ago
EWTX
Edgewise Therapeutics, Inc. Is Worried About This – Should You Be Worried Too?
PremiumCompany AnnouncementsEdgewise Therapeutics, Inc. Is Worried About This – Should You Be Worried Too?
2M ago
EWTX
Edgewise Therapeutics reports Q4 EPS (47c), consensus (43c)
PremiumThe Fly
Edgewise Therapeutics reports Q4 EPS (47c), consensus (43c)
2M ago
EWTX
FDA grants Edgewise fast track designation for EDG-5506 to treat Duchenne
PremiumThe Fly
FDA grants Edgewise fast track designation for EDG-5506 to treat Duchenne
2M ago
EWTX
Edgewise Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Edgewise Therapeutics management to meet with Piper Sandler
3M ago
EWTX
Edgewise Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Edgewise Therapeutics management to meet with Piper Sandler
3M ago
EWTX
Edgewise Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Edgewise Therapeutics management to meet with Piper Sandler
3M ago
EWTX
Edgewise Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Edgewise Therapeutics management to meet with Piper Sandler
3M ago
EWTX
Fly Insider: Edgewise,Arch Resources among week’s notable insider trades
PremiumThe FlyFly Insider: Edgewise,Arch Resources among week’s notable insider trades
3M ago
NN
AZO
Fly Insider: Edgewise, Arch Resources among week’s notable insider trades
PremiumThe Fly
Fly Insider: Edgewise, Arch Resources among week’s notable insider trades
3M ago
NN
AZO
Edgewise Therapeutics Strikes $240M Stock Sale Deal
PremiumMarket News
Edgewise Therapeutics Strikes $240M Stock Sale Deal
3M ago
8K
EWTX
Edgewise Therapeutics 21.8M share Secondary priced at $11.00
PremiumThe Fly
Edgewise Therapeutics 21.8M share Secondary priced at $11.00
3M ago
EWTX
Edgewise, Caribou higher after WSJ report of Cytokinetics buyout
PremiumThe Fly
Edgewise, Caribou higher after WSJ report of Cytokinetics buyout
4M ago
CRBU
CYTK
Edgewise shares still reflect limited credit for EDG-7500, says Wedbush
PremiumThe Fly
Edgewise shares still reflect limited credit for EDG-7500, says Wedbush
4M ago
BMY
CYTK
Edgewise Therapeutics rises after Cytokinetics succeeds in HCM trial
PremiumThe Fly
Edgewise Therapeutics rises after Cytokinetics succeeds in HCM trial
4M ago
CYTK
EWTX
Oppenheimer, Wedbush say buy these biotech stocks for 2024
PremiumThe FlyOppenheimer, Wedbush say buy these biotech stocks for 2024
5M ago
DYN
ALPN
Oppenheimer, Wedbush say buy these biotech stocks for 2024
PremiumThe Fly
Oppenheimer, Wedbush say buy these biotech stocks for 2024
5M ago
DYN
ALPN
FDA grants Edgewise ODD, RPDD for EDG-5506 to treat Duchenne, Becker MD
PremiumThe Fly
FDA grants Edgewise ODD, RPDD for EDG-5506 to treat Duchenne, Becker MD
5M ago
EWTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >